Mechanistically, fbxo22 promotes the transcription of Rad51 gene by increasing the level of FoxM1 at the Rad51 promoter, thereby reducing the sensitivity of lung cancer cells to radiotherapy (Li et al., 2021). This evidence concerns the gene RAD51 and lung carcinoma.